Roche: launch of Elecsys Anti-p53 test
(CercleFinance.com) - Roche has announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies, which is now available for all markets that accept the CE mark.
The test is used to help physicians diagnose throat cancer, bowel cancer and breast cancer in patients, in conjunction with other diagnostic tests, it said.
The Swiss health laboratory explains that anti-p53 antibodies are antibodies that mistakenly target a patient's own tissue, leading to tumour growth.
Copyright (c) 2021 CercleFinance.com. All rights reserved.
The test is used to help physicians diagnose throat cancer, bowel cancer and breast cancer in patients, in conjunction with other diagnostic tests, it said.
The Swiss health laboratory explains that anti-p53 antibodies are antibodies that mistakenly target a patient's own tissue, leading to tumour growth.
Copyright (c) 2021 CercleFinance.com. All rights reserved.